Skip to main content

NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

OPPA regimen

View Patient Information

A regimen consisting of vincristine, prednisone, procarbazine and doxorubicin (OPPA) used in combination with radiation therapy for the treatment of female patients with childhood Hodgkin lymphoma with low-risk features.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	GPOH-HD 95 regimen Oncovin-prednisone-procarbazine-Adriamycin regimen OPPA

OPPA regimen

Search NCI's Drug Dictionary